Features of medication overuse headache following overuse of different acute headache drugs.
about
Recent advances in migraine therapyChronic Pain in Children and Adolescents: Diagnosis and Treatment of Primary Pain Disorders in Head, Abdomen, Muscles and JointsMigraine: diagnosis and managementNeural hyperactivity in the amygdala induced by chronic treatment of rats with analgesics may elucidate the mechanisms underlying psychiatric comorbidities associated with medication-overuse headache.Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.Tension-type headache with medication overuse: pathophysiology and clinical implications.Medication-overuse headache: a reviewIncreased susceptibility to cortical spreading depression in an animal model of medication-overuse headacheMedication-overuse headache: epidemiology, diagnosis and treatmentChronic migraine--classification, characteristics and treatment.Medication overuse headaches -- what is new?Medication overuse headache: history, features, prevention and management strategies.Correlation between lipophilicity and triptan outcomes.The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache.Antiepileptic drugs for the treatment of chronic and episodic cluster headache: a review.Medication-overuse headache in patients with cluster headache.Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.Sustained morphine-induced sensitization and loss of diffuse noxious inhibitory controls in dura-sensitive medullary dorsal horn neurons.HeadachesThe changing face of migraine.The use of botulinum neurotoxin type A (Botox) for headaches: a case review.Managing chronic headaches in the clinic.Topiramate in migraine prevention.Management of chronic daily headache: challenges in clinical practice.From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries.Prevalence of migraine and tension-type headache among adults in JordanMedication-overuse headache.Triptans in the Italian population: a drug utilization study and a literature review.Increased activity of serotonin uptake in platelets in medication overuse headache following regular intake of analgesics and triptansDrug-dependence behaviour and outcome of medication-overuse headache after treatment.What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment.Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study.Preventive agents for migraine: focus on the antiepileptic drugs.Neurovascular pains: implications of migraine for the oral and maxillofacial surgeon.Patterns of triptans use: a study based on the records of a community pharmaceutical department.Management of medication-overuse headache.From migraine to chronic daily headache: the biological basis of headache transformation.Elevated blood pressure and analgesic overuse in chronic daily headache: an outpatient clinic-based study from ChinaOptimizing prophylactic treatment of migraine: Subtypes and patient matching.Past, present, and future prospects of medication-overuse headache classification.
P2860
Q26743537-F2CEE3CA-11AD-4CC0-8BFC-C6C462F5F286Q28069591-925D34DB-F1C0-4B6E-99F9-555CB70D9161Q28165454-436ED797-5171-4570-BF8E-54E84C2473E5Q30833705-B9F59EC4-C0B6-4E44-AA8B-7A305168B620Q31147645-51A5D533-2D67-4438-A1E8-EF1CFF24EBC2Q33647477-FD4F3850-0D0A-4D43-AFF7-20A55216F2BEQ33838844-A35D6704-40FB-4EDF-9861-CF60B4C64BA1Q33921986-37ED56C7-C765-47EB-802E-6AA5F56B25C8Q33949551-53E19D17-6D8E-431F-8D6E-E199679B3673Q34030691-A80D3420-61F3-471E-ADFD-3698881D62D1Q34220383-00E635B9-E98A-43B0-8E98-699D3AC766FCQ34362586-356B37F7-CB8D-4419-92CD-2108B6C2C6FCQ34386762-D1D06298-460B-4740-A217-147CC4001B66Q34420699-DA43FF5F-8CFF-42CE-9B60-E8BAF73BD22BQ34577528-191A6B95-5BF2-4780-A216-6FE07204408BQ34778194-111D9406-87EB-4D71-A01F-D8BEA8335B51Q35116532-50ABAF05-7612-4B66-9649-F62D017D61FCQ35226089-1D383C68-C833-4EFE-BF6E-14FEABDEB37AQ35623043-D1874D14-BB17-406C-9246-D925013DCA12Q35674026-025ABFA3-08F9-4F40-B920-B46E8C352AB1Q35729516-1BB81FFB-5F05-4553-B3BC-FF93419D2F28Q36007281-3CB988CC-8252-4016-88C3-84A10F38D649Q36099519-71A8295C-094C-43B3-8729-1B9D9D7C72BDQ36099528-1704C52B-35D6-47A6-87A3-E185524FA952Q36259584-B2A3DA52-D493-4D66-B3B4-2BE1B7DBA6EDQ36259784-E27E0CA4-8863-4E82-B86D-D99BA2F84BE3Q36311001-69955818-785D-4970-9970-546437443C50Q36332554-3392729A-8009-490A-97D3-C775F50A80F9Q36332563-C4A1D8CC-81C3-4CD5-992C-F3ED44564FCFQ36357131-BA1CCBAE-2F20-459F-ADF3-60F95C149FB7Q36429811-3A7B47F3-0E0E-4890-8EDF-671F4897464AQ36665340-4F044A3F-41FF-403D-8739-A874EF8D520DQ36748706-698A86B4-A9D4-4F7F-B5D2-4F0E7F0DBD56Q36772194-717C42CE-2A5F-48B8-B425-BA05F14C496FQ36903088-980B7381-600A-4D54-BD18-351AA38A2F10Q36941902-9D336C53-9F73-4F0C-8880-AABCCD3192FEQ36947165-398AB415-A2D2-4F59-83AF-B3EB1E04EEABQ36952569-78AA452D-F240-4554-B72D-F416E97B6211Q37052803-33807750-D898-4C5E-8628-E22F7C562DC4Q37237792-6EA066F7-A994-4E90-AEFD-13E9C145C9FB
P2860
Features of medication overuse headache following overuse of different acute headache drugs.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Features of medication overuse ...... ifferent acute headache drugs.
@en
Features of medication overuse ...... ifferent acute headache drugs.
@nl
type
label
Features of medication overuse ...... ifferent acute headache drugs.
@en
Features of medication overuse ...... ifferent acute headache drugs.
@nl
prefLabel
Features of medication overuse ...... ifferent acute headache drugs.
@en
Features of medication overuse ...... ifferent acute headache drugs.
@nl
P2093
P356
P1433
P1476
Features of medication overuse ...... ifferent acute headache drugs.
@en
P2093
Fritsche G
Katsarava Z
Limmroth V
Przywara S
P304
P356
10.1212/WNL.59.7.1011
P407
P577
2002-10-01T00:00:00Z